Effect of Neutralizing Antibodies Against GM-CSF, G-CSF, and IL-3 on Spontaneous CFU-GM Growth From Normal Human PB-MNCs
Exp. No. . | Control . | Neutralizing Antibodies Against . | ||||||
---|---|---|---|---|---|---|---|---|
. | . | GM-CSF . | G-CSF . | IL-3 . | GM-CSF . | GM-CSF . | G-CSF . | G-/GM-CSF, IL-3 . |
. | . | . | . | . | G-CSF . | IL-3 . | IL-3 . | . |
1 | 13.3 | 0.3 | 8.6 | 12.6 | 0 | 0.3 | 8.6 | 0 |
2 | 20.6 | 2.3 | 13 | 21.6 | 0 | 2.3 | 14.6 | 0 |
3 | 20 | 2 | 16.6 | 20 | 0.3 | 3 | 17 | 0 |
4 | 18 | 1.66 | 17 | 17.6 | 0 | 2 | 17.6 | 0 |
Mean ± SEM | 18 ± 1.7 | 1.6 ± 1.6 | 13.8 ± 2 | 18 ± 2 | 0.1 ± 0.1 | 1.9 ± 0.6 | 14.5 ± 2.1 | 0 |
% Inhibition | 91.13-150 | 23.33-151 | 0† | 99.43-150 | 89.43-150 | 19.43-151 | 1003-150 |
Exp. No. . | Control . | Neutralizing Antibodies Against . | ||||||
---|---|---|---|---|---|---|---|---|
. | . | GM-CSF . | G-CSF . | IL-3 . | GM-CSF . | GM-CSF . | G-CSF . | G-/GM-CSF, IL-3 . |
. | . | . | . | . | G-CSF . | IL-3 . | IL-3 . | . |
1 | 13.3 | 0.3 | 8.6 | 12.6 | 0 | 0.3 | 8.6 | 0 |
2 | 20.6 | 2.3 | 13 | 21.6 | 0 | 2.3 | 14.6 | 0 |
3 | 20 | 2 | 16.6 | 20 | 0.3 | 3 | 17 | 0 |
4 | 18 | 1.66 | 17 | 17.6 | 0 | 2 | 17.6 | 0 |
Mean ± SEM | 18 ± 1.7 | 1.6 ± 1.6 | 13.8 ± 2 | 18 ± 2 | 0.1 ± 0.1 | 1.9 ± 0.6 | 14.5 ± 2.1 | 0 |
% Inhibition | 91.13-150 | 23.33-151 | 0† | 99.43-150 | 89.43-150 | 19.43-151 | 1003-150 |
PB-MNCs (2 × 105/mL) were cultured in methylcellulose containing 30% FCS and IMDM together with neutralizing antibodies against GM-CSF, G-CSF, IL-3, or combinations of these without exogenous CSF. Colony growth was assessed after 14 days. The mean colony numbers of triplicates are given from four experiments.
P < .01.
P > .05.